Prospect of rindopepimut in the treatment of glioblastoma

INTRODUCTION: Rindopepimut (CDX-110) is a peptide vaccine that targets epidermal growth factor receptor variant III (EGFRvIII), a tumor-specific epitope expressed in the most common and lethal primary malignant neoplasm of the brain – glioblastoma (GBM). AREAS COVERED: The EGFRvIII mutation introduc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Expert Opin Biol Ther
Main Authors: Elsamadicy, Aladine A., Chongsathidkiet, Pakawat, Desai, Rupen, Woroniecka, Karolina, Farber, S. Harrison, Fecci, Peter E., Sampson, John H.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5787389/
https://ncbi.nlm.nih.gov/pubmed/28274144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2017.1299705
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares